Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 72

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 72
---
 been completed in order to cover syndicate short positions. Penalty bids permit the underwriters
to reclaim selling concessions from dealers when the securities originally sold by the dealers are purchased in covering transactions
to cover syndicate short positions. These transactions may cause the price of the securities sold in an offering to be higher than it
would otherwise be. These transactions, if commenced, may be discontinued by the underwriters at any time.

Any securities other than our common stock issued
hereunder may be new issues of securities with no established trading market. Any underwriters or agents to or through whom such securities
are sold for public offering and sale may make a market in such securities, but such underwriters or agents will not be obligated to do
so and may discontinue any market making at any time without notice. No assurance can be given as to the liquidity of the trading market
for any such securities. The amount of expenses expected to be incurred by us in connection with any issuance of securities will be set
forth in the applicable prospectus supplement. Certain of the underwriters, dealers or agents and their associates may engage in transactions
with, and perform services for, us and certain of our affiliates in the ordinary course of business.

During such time as we may be engaged in a distribution
of the securities covered by this prospectus we are required to comply with Regulation M promulgated under the Exchange Act. With certain
exceptions, Regulation M precludes us, any affiliated purchasers, and any broker-dealer or other person who participates in such distribution
from bidding for or purchasing, or attempting to induce any person to bid for or purchase, any security which is the subject of the distribution
until the entire distribution is complete. Regulation M also restricts bids or purchases made in order to stabilize the price of a security
in connection with the distribution of that security. All of the foregoing may affect the marketability of our shares of common stock.

<div align='center'>24

LEGAL MATTERS</div>

The validity and legality of the securities offered
hereby and certain other legal matters will be passed upon for the Company by K&L Gates LLP, Charlotte, North Carolina.

<div align='center'>EXPERTS</div>

RBSM LLP, independent registered public accounting
firm, has audited our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024, which is incorporated
by reference into this prospectus and elsewhere in the registration statement of which this prospectus is